📣 Try out the NEW Gateway to Research and let us know what you think.

We're looking for users to test the new service during August and September and share their feedback. Express your interest by completing this short form.

A Recombinant Chimeric Protein-Based Vaccine Containing T-Cell Epitopes from Amastigote Proteins and Combined with Distinct Adjuvants, Induces Immunogenicity and Protection against Leishmania infantum Infection. (2022)

First Author: Lage DP

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.3390/vaccines10071146

PubMed Identifier: 35891310

Publication URI: http://europepmc.org/abstract/MED/35891310

Type: Journal Article/Review

Volume: 10

Parent Publication: Vaccines

Issue: 7

ISSN: 2076-393X